Skip to main content
editorial
. 2021 Mar 30;64(6):647–649. doi: 10.1165/rcmb.2021-0134ED

Figure 1.

Figure 1.

Proposed mechanism of coagulopathy in lungs of patients with coronavirus disease (COVID-19). Figure was created with BioRender.com. PAI-2 = plasminogen activator inhibitor-2; PBMCs = peripheral blood mononuclear cells; PLAU = plasminogen activator urokinase; PLAUR = plasminogen activator urokinase receptor; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2; TFPI = tissue factor pathway inhibitor.